An Observational study comparing the impact of renal function associated with warfarin versus rivaroxaban in patients with non-valvular atrial fibrillation (NVAF)

Trial Profile

An Observational study comparing the impact of renal function associated with warfarin versus rivaroxaban in patients with non-valvular atrial fibrillation (NVAF)

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Oct 2016

At a glance

  • Drugs Rivaroxaban (Primary) ; Warfarin
  • Indications Atrial fibrillation
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 08 Oct 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top